10 Big Names With Explosive Growth

Page 9 of 9

1. Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Intellia rallied to a new all-time high on Wednesday, as investors took path from two investment firms’ “buy” recommendations for its stock.

During the session, Intellia Therapeutics, Inc. (NASDAQ:NTLA) soared to an all-time high of $26.46 before paring gains to end the day just up by 19.72 percent at $24.47 apiece.

In a market note, Zacks Research upgraded its stock to a “buy” recommendation amid an upward trend in earnings estimates from Wall Street analysts.

“Rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company’s underlying business. And investors’ appreciation of this improving business trend should push the stock higher,” it said.

Meanwhile, Intellia Therapeutics, Inc. (NASDAQ:NTLA) also earned an “outperform” rating and a price target of $33 from JMP Securities, with the upgrade buoyed by a strengthened outlook for its hereditary angioedema (HAE) program.

According to the investment firm, the company’s drug candidate, Ionvo-Z, could capture a 19-percent market share and potentially translate to $2.8 billion market opportunity.

While we acknowledge the potential of NTLA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NTLA and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.

Page 9 of 9